Tracking – and tackling – infectious diseases with new technologies
The COVID-19 pandemic exposed a critical need to improve the detection, containment and management of infectious disease outbreaks. The global scientific community rallied to meet the challenges by developing novel technologies including mRNA vaccine platforms, rapid at-home diagnostic tests and international genomic surveillance networks to detect new variants.
At the Scripps Research Digital Trials Center, scientists leveraged their extensive expertise in mobile app-based digital trials and the analysis of wearable sensor data to gain valuable insights into key facets of COVID-19, including the early onset of illness, disease severity, prolonged effects of infection, vaccine response and disease rebound.
Epidemiologists, artificial intelligence specialists and digital trial experts continue to work with partners around the globe to develop new tools and knowledge to bring an end to the current pandemic, while preparing the world to more effectively respond to future pandemic threats.